- $107.94bn
- $126.85bn
- $32.36bn
- 86
- 52
- 88
- 89
Annual balance sheet for Medtronic, fiscal year end - April 26th, USD millions except per share, conversion factor applied.
2020 April 24th | 2021 April 30th | 2022 April 29th | 2023 April 28th | 2024 April 26th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 10,948 | 10,817 | 10,573 | 7,959 | 8,005 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4,645 | 5,462 | 5,551 | 5,998 | 6,128 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 22,031 | 22,548 | 23,059 | 21,675 | 21,935 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 5,755 | 6,219 | 6,267 | 6,610 | 7,143 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 90,689 | 93,083 | 90,981 | 90,948 | 89,981 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 10,366 | 8,509 | 12,394 | 9,051 | 10,789 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 39,952 | 41,655 | 38,430 | 39,465 | 39,767 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 50,737 | 51,428 | 52,551 | 51,483 | 50,214 |
Total Liabilities & Shareholders' Equity | 90,689 | 93,083 | 90,981 | 90,948 | 89,981 |
Total Common Shares Outstanding |